MSAA vs myVUMERITY
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
MSAA
This free mobile application assists individuals with Multiple Sclerosis (MS) and their care partners in managing their condition. It provides a convenient tool to help users track and understand their MS journey, aligning with the mission to improve lives.
- MS management tool
- For MS patients
- For care partners
- Free mobile application
- Optimized for iPhone/iPad
Read full descriptionHide full description
Welcome to the new and improved My MS Manager™, a free mobile phone application created by the Multiple Sclerosis Association of America (MSAA) in partnership with @Point of Care for individuals with Multiple Sclerosis (MS) and/or their care partner. This convenient and effective tool is designed to help you manage your MS, consistent with MSAA’s mission of improving lives today. Optimized for iPhone or iPad. Need help getting the app? Have feedback? Call 1-800-772-8277, ext 178 to get assistance. If you have questions about MS that are not related to this App, please e-mail Msquestions@mymsaa.org or call 1-800-532-7667, ext. 154, for assistance.
myVUMERITY
This app helps users manage their VUMERITY treatment by tracking daily doses, setting reminders, and logging lab tests. It facilitates better preparation for discussions with healthcare providers.
- Track daily doses
- Personalized treatment reminders
- Keep track of lab tests
- Access activity log
- Prepare for healthcare provider conversations
Read full descriptionHide full description
myVUMERITY is an app brought to you by Biogen that can help you keep track of your VUMERITY (diroximel fumarate) treatment. Download the application to: * Track daily doses * Set up personalized treatment reminders * Keep track of your lab tests * Access your activity log on the go By using myVUMERITY on a regular basis, you can keep track of your VUMERITY treatment and better prepare for a productive conversation with your healthcare provider. For Important Safety Information, please see full Prescribing Information at https://www.VUMERITY.com/pdfs/full-prescribing-info.pdf and Patient Information at https://www.VUMERITY.com/pdfs/patient-information.pdf. This is not intended to replace discussions with your healthcare provider.
Screenshots
Verdict
The clearest difference is rating: MSAA at 3.6 against myVUMERITY's 3.1. MSAA also leads on iOS requirement (14.0 vs 17.6). myVUMERITY's advantage is review sentiment (33% vs 22%). On price, ratings volume, update cadence and ads there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
MSAA holds the better App Store score, 3.6 against 3.1. Both are backed by a comparable volume of ratings — 22 and 19 respectively. Written reviews complicate that: 22% of MSAA's written reviews are positive against 33% of myVUMERITY's, so the app with the better star average is not the one people write more warmly about.
Both ship on a similar rhythm, roughly every 2 months. The most recent releases landed on September 23, 2026 and September 13, 2026 respectively.
| Parameter | MSAA | myVUMERITY |
|---|---|---|
| Price | Free | Free |
| Rating | 3.6 (22 ratings) — better | 3.1 (19 ratings) |
| Positive reviews | 21.9% of reviews | 33.3% of reviews — better |
| Number of ratings | 22 — better | 19 |
| Update frequency | Every 2 months | Every 2 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod — better | iPhone, iPod |
| Requires iOS | 14.0 — better | 17.6 |
| Further details — not scored | ||
| Size | 20 MB | 27 MB |
| Age rating | 12+ | 17+ |
| Developer | @Point of Care | Biogen Inc. |
Customer experience
MSAA
myVUMERITY
In-app purchases
MSAA
No in-app purchases
myVUMERITY
No in-app purchases
